Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Shanghai Fosun Pharmaceutical Group Co Ltd proposes issuance of new H shares of the company


Monday, 20 Jan 2014 07:30am EST 

Shanghai Fosun Pharmaceutical Group Co Ltd:Says an issue of new H Shares shall not exceed 20 pct of that of the H Shares in issue as at Dec. 20, 2013, being the date of the 2013 first extraordinary general meeting of the company.The number of the new H Shares shall not exceed 67,214,000 H Shares based on the total number of 336,070,000 H Shares in issue as at Dec. 20, 2013.The proceeds to be raised from the issuance of the new H Shares, after deduction of the expenses relating to the issuance, will be used to repay interest-bearing debts, replenish the working capital of the group, and finance potential mergers and acquisitions domestically or overseas.